Anthonie Janse1, Stephanie Nikolaus2, Jan F Wiborg2, Marianne Heins2, Jos W M van der Meer3, Gijs Bleijenberg4, Marcia Tummers5, Jos Twisk6, Hans Knoop7. 1. Expert Center for Chronic Fatigue, Department of Medical Psychology, Amsterdam Public Health research institute, Vrije Universiteit Amsterdam, The Netherlands; Academic Medical Center (AMC), University of Amsterdam, Department of Medical Psychology, Amsterdam Public Health research institute, Amsterdam, The Netherlands. 2. Expert Center for Chronic Fatigue, Department of Medical Psychology, Amsterdam Public Health research institute, Vrije Universiteit Amsterdam, The Netherlands. 3. Department of Internal Medicine, Radboud university medical center, Nijmegen, The Netherlands. 4. Radboud university medical center, Nijmegen, The Netherlands. 5. Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands. 6. Department of Methodology and Applied Biostatistics, Vrije Universiteit, Amsterdam, The Netherlands. 7. Expert Center for Chronic Fatigue, Department of Medical Psychology, Amsterdam Public Health research institute, Vrije Universiteit Amsterdam, The Netherlands; Academic Medical Center (AMC), University of Amsterdam, Department of Medical Psychology, Amsterdam Public Health research institute, Amsterdam, The Netherlands. Electronic address: hans.knoop@amc.uva.nl.
Abstract
OBJECTIVE: Cognitive behaviour therapy (CBT) is an effective treatment for chronic fatigue syndrome (CFS). Main aim was to determine whether treatment effects were maintained up to 10years after treatment. METHODS: Participants (n=583) of previously published studies on the effects of CBT for CFS were contacted for a long-term follow-up assessment. They completed questionnaires on main outcomes fatigue severity (CIS) and physical functioning (SF-36). The course of these outcomes since post-treatment assessment was examined using mixed model analyses. RESULTS: Between 21 and 125months after finishing CBT, 511 persons (response rate 88%) completed a follow-up assessment. At follow-up, mean fatigue severity was significantly increased to 37.60 (SD=12.76) and mean physical functioning significantly decreased to 73.16 (SD=23.56) compared to post-treatment assessment. At follow-up still 37% of the participants had fatigue scores in the normal range and 70% were not impaired in physical functioning. CONCLUSION: Positive effects of CBT for CFS on fatigue and physical functioning were partly sustained at long-term follow-up. However, a subgroup of patients once again reported severe fatigue, and compromised physical functioning. Further research should elucidate the reasons for this deterioration to facilitate the development of treatment strategies for relapse prevention.
OBJECTIVE: Cognitive behaviour therapy (CBT) is an effective treatment for chronic fatigue syndrome (CFS). Main aim was to determine whether treatment effects were maintained up to 10years after treatment. METHODS:Participants (n=583) of previously published studies on the effects of CBT for CFS were contacted for a long-term follow-up assessment. They completed questionnaires on main outcomes fatigue severity (CIS) and physical functioning (SF-36). The course of these outcomes since post-treatment assessment was examined using mixed model analyses. RESULTS: Between 21 and 125months after finishing CBT, 511 persons (response rate 88%) completed a follow-up assessment. At follow-up, mean fatigue severity was significantly increased to 37.60 (SD=12.76) and mean physical functioning significantly decreased to 73.16 (SD=23.56) compared to post-treatment assessment. At follow-up still 37% of the participants had fatigue scores in the normal range and 70% were not impaired in physical functioning. CONCLUSION: Positive effects of CBT for CFS on fatigue and physical functioning were partly sustained at long-term follow-up. However, a subgroup of patients once again reported severe fatigue, and compromised physical functioning. Further research should elucidate the reasons for this deterioration to facilitate the development of treatment strategies for relapse prevention.
Authors: Lidewij D Van Gessel; Harriët J G Abrahams; Hetty Prinsen; Gijs Bleijenberg; Marianne Heins; Jos Twisk; Hanneke W M Van Laarhoven; Stans C A H H V M Verhagen; Marieke F M Gielissen; Hans Knoop Journal: J Cancer Surviv Date: 2018-04-12 Impact factor: 4.442
Authors: Maud De Venter; Jela Illegems; Rita Van Royen; Bernard G C Sabbe; Greta Moorkens; Filip Van Den Eede Journal: Front Psychiatry Date: 2020-06-12 Impact factor: 4.157
Authors: Katharina Kuba; Gregor Weißflog; Heide Götze; Francisco García-Torres; Anja Mehnert; Peter Esser Journal: Int J Clin Health Psychol Date: 2019-01-16
Authors: Margreet Worm-Smeitink; Arno van Dam; Saskia van Es; Rosalie van der Vaart; Andrea Evers; Michel Wensing; Hans Knoop Journal: J Med Internet Res Date: 2019-10-10 Impact factor: 5.428
Authors: Merethe Eide Gotaas; Tore C Stiles; Johan Håkon Bjørngaard; Petter C Borchgrevink; Egil A Fors Journal: Front Psychiatry Date: 2021-04-12 Impact factor: 4.157
Authors: T A Kuut; F Müller; A Aldenkamp; E Assmann-Schuilwerve; A Braamse; S E Geerlings; K B Gibney; R A A Kanaan; P Nieuwkerk; T C Olde Hartman; D Pauëlsen; M Prins; K Slieker; M Van Vugt; C P Bleeker-Rovers; S P Keijmel; H Knoop Journal: Trials Date: 2021-12-02 Impact factor: 2.279
Authors: Ruud Raijmakers; Megan Roerink; Stephan Keijmel; Leo Joosten; Mihai Netea; Jos van der Meer; Hans Knoop; Hans Klein; Chantal Bleeker-Rovers; Janine Doorduin Journal: Neurol Neuroimmunol Neuroinflamm Date: 2021-11-23